As the world leader in digital medication adherence monitoring for successful clinical trials, AARDEX is proud to announce its collaboration with 4 Belgian/Swiss financial partners to assist company’s growth.

SRIW, Sowalfin, Noshaq and CCF (Centre de Cautionnement et de Financement du Valais) are now part of the AARDEX Adventure.

Back to news
Further information and contact
Contact Us
Recent Post

AARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence

By Jonathan Joaquim | October 1, 2020

AARDEX announces the world’s first DIGITAL MEDICATION ADHERENCE MONITORING solution fully integrated in the clinical trial platform by a top 10 pharma company.

By aardexwp | June 19, 2020

How digital medication adherence monitoring increases the impact of innovative adherence research?

By aardexwp | June 12, 2020

AARDEX Group announces the opening of a new office in the U.S.

By aardexwp | May 5, 2020

Using data science to detect key changes in medication intake behaviors.

By aardexwp | April 29, 2020